External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AACR 2026
Roche and Genentech at

AACR 2026

April 17 - April 22
San Diego, USA / Virtual (Hybrid)
aacr.org
We will be contributing to topics related to
Oncology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
04:00 PM
Duration 180mins San Diego, USA
A liquid biopsy assay of estrogen receptor activity predicts response to giredestrant in ER+/HER2− advanced breast cancer
Annie Collier, Aparna Gorthi, Corrie Painter, J. Carl Barrett, James Sullivan, Jing Zhu, Jonathan Beagan, Khoi Nguyen, Kristian Cibulskis, Mary Mcgillicuddy, Matthew Eaton, Pablo Diego Perez-Moreno, Richard Schwab, Tharu Fernando, Travis Clark
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 180mins San Diego, USA
Phase I study of ERY974 in patients with glypican-3 (GPC-3)-positive advanced solid tumors
Haruyasu Murakami, Hidetoshi Hayashi, Kensei Yamagushi, Kei Muro, Taroh Satoh, Tomohiro Nishina, Eisuke Ueda, Chika Ogami, Hitomi Takeshita, Hayato Takahashi, Mikiko Nakamura, Mihiro Toba, Yasutoshi Kuboki
Oncology | Liver Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 PM
Duration 180mins San Diego, USA
Leveraging Enhanced Conversion Efficiency of the KAPA EvoPrep Boost Workflow for Urine ctDNA Detection
Angela Apessos, Maria Shin, Stephanie Yaung, Indira Wu
Oncology | Urinary Bladder Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:00 PM
Duration 180mins San Diego, USA
Pb-based CEA pretargeted radioimmunotherapy demonstrates tumor targeting and potent TGI in immunodeficient and humanized mouse models, informing a FIH study in mCRC
Sofia Frost, Alexandre Pichard, Annabelle Mouchotte, Agnès Colmont, Sara Colombetti, Alexander Haas, Hans Peter Grimm, Birgit Kittel, Stephen Fowler, Bernhard Reis, Vincent Wolowski, Uta Sweere, Michael Hettich, Wolfgang Jacob, Frederic Prince, Christian Klein, Pablo Umana, Julien Torgue, Axel Boehnke
Oncology | Gastrointestinal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.